Boutayeb Saber

Professeur agrégé

Spécialité : Oncologie médicale

ID-IRC : 1919020036

Domaine de Maîtrise :
Nouvelles Technologies, Ingénierie, Systèmes d’Information et IA

Organisme d’appartenance :
Faculté de médecine et de pharmacie de Rabat

Domaine d’intérêt :
Nouvelles Technologies, Ingénierie, Systèmes d’Information et IA

Les publications :

1. Probable paclitaxel-induced pancreatitis: uncommon case report and literature review.Raiss H, et al. J Gastrointest Oncol. 2017

2. [Evaluation of multidisciplinary team meeting; the example of gynecological mammary cancers in a tertiary referral center in Morocco].Chaouki W, et al. Bull Cancer. 2017

3. Chemonaïveté in inoperable malignant bowel obstruction.Boutayeb S, et al. Curr Oncol. 2017

4. First line chemotherapy plus trastuzumab in metastatic breast cancer HER2 positive – Observational institutional study.Clinical trialAitelhaj M, et al. Pan Afr Med J. 2016

5. Quality of life of early stage colorectal cancer patients in Morocco.Mrabti H, et al. BMC Gastroenterol. 2016

6. Which Epidemiological Factors Have the Most Influence on the EGFR Mutation Frequency in Lung Adenocarcinoma?Elghissassi I, et al. J Thorac Oncol. 2016

7. Peritoneal carcinomatosis, an unusual and only site of metastasis from lung adenocarcinoma.Hanane K, et al. Pan Afr Med J. 2016

8. Isolated splenic metastasis from colon cancer: Case report.Review articleAbdou J, et al. World J Gastroenterol. 2016

9. Second-line treatment of non-small-cell lung cancer with wild-type EGFR status. What is the best approach?Elghissassi I, et al. Curr Oncol. 2016

10. [Leiomyosarcoma of the bladder in a 64 year old patient].Elkabous M, et al. Pan Afr Med J. 2015

Menu